Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...
In a “true pivot” in asthma care across the UK, new guidelines urge medics to offer inhalers that both relieve and prevent symptoms to newly diagnosed sufferers who are 12 and over ...
Flovent, a corticosteroid treatment now sold under its generic name fluticasone propionate, was one of the most commonly prescribed pediatric asthma treatments, in particular because the inhaler ...